Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Proangiogenic effect and molecular mechanism of a new cytosporin derivative from the marine fungus Eutypella sp. D-1.

Created on 14 Jul 2026

Authors

Xiaoyue Sun, Ranran Zhu, Qijia Feng, Peihai Li, Yun Zhang, Qing Xia, Kechun Liu, Xuehui Jian, Yuanshuai Yu, Xue Wang, Chen Sun, Haobing Yu

Published in

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents. Volume 35. Issue 5. Pages 974-985. Epub Apr 07, 2026.

Abstract

A new cytosporin derivative, cytoeutypellane D, was isolated from a culture extract of the Arctic-derived fungus Eutypella sp. D-1. Its structure was determined based on a detailed nuclear magnetic resonance spectroscopic interpretation, a mass spectrometry data analysis, and a literature review. Zebrafish were used in in vivo experiments to discover that the isolated compound significantly promoted angiogenesis in a dose-dependent manner. Further studies regarding the underlying mechanisms revealed that it may target the VEGF/VEGFR2 signaling pathway and rescue abnormal expressions of the cdk1, aurkb, topbp1, and brca2 genes to improve vascular endothelial cell proliferation and migration in zebrafish. In summary, our findings suggested that this novel compound isolated from the fungus Eutypella sp. D-1 might be used as a promising molecule for vascular injury disease treatment.

PMID:
42446555
Bibliographic data and abstract were imported from PubMed on 14 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement